Variables | Brazil nut (n = 35) Δ T90 – T0 | Placebo (n = 42) Δ T90 – T0 | P value intragroupa | P value intragroupb | P value intergroupc |
---|---|---|---|---|---|
FT3 (pg/mL) | 0.1 ± 1.1 | −0.1 ± 0.4 | NS | 0.030* | NS |
FT4 (ng/dL) | 0.1 ± 0.6 | −0.1 ± 0.1 | NS | NS | NS |
TSH (μUI/mL) | 0.2 ± 1.8 | −0.2 ± 0.9 | NS | NS | 0.06 |
SBP (mmHg) | 3.5 ± 18.0 | −4.0 ± 30.7 | NS | NS | NS |
DBP (mmHg) | −1.5 ± 13.6 | −5.0 ± 15.2 | NS | 0.020* | NS |
Total cholesterol (mg/dL) | −20.5 ± 61.2 | −7.4 ± 44.5 | 0.020* | NS | NS |
LDL-cholesterol (mg/dL) | −6.4 ± 57.9 | −6.5 ± 39.5 | NS | NS | NS |
HDL-cholesterol (mg/dL) | −1.0 ± 5.0 | 0.8 ± 7.1 | NS | NS | NS |
Triglycerides (mg/dL) | −49.6 ± 198.2 | −0.05 ± 104.1 | NS | NS | NS |
Non-HDL cholesterol (mg/dL) | −19.5 ± 61.2 | −8.2 ± 44.5 | 0.020* | NS | NS |
Apolipoprotein A-1 (mg/dL) | −10.2 ± 26.7 | −7.9 ± 27.8 | 0.040* | NS | NS |
Apolipoprotein B (mg/dL) | −5.2 ± 25.9 | −5.0 ± 23.4 | NS | NS | NS |
ApoB/ApoA-1 ratio | 0.02 ± 0.2 | −0.06 ± 0.3 | NS | NS | NS |
Lp(a) (mg/dl) | −0.5 ± 23.7 | 5.9 ± 18.0 | NS | 0.02* | NS |